An Act protecting patient safety regarding non-FDA approved drugs
Accompanied a study order, see H5234
Email me when H 2472 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 2472. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill forbids any retail pharmacy in Massachusetts from selling compounded medications to anyone other than the patient for whom they were prepared. It also requires detailed labeling on compounded drugs and gives the state pharmacy board authority to fine, suspend, or revoke licenses for violations. The goal is to protect patient safety by ensuring compounded drugs are used only as intended.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 2472
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Accompanied a study order, see H5234
- Reporting date extended to Thursday, October 9, 2025
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Senate concurred
- Referred to the committee on Public Health
Sponsors
- Kathleen R. LaNatra (D) · sponsor
- Patrick Joseph Kearney
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 2472 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 2472 freeOr ask your AI assistant about H 2472 directly:
Add to Claude, ChatGPT or Cursor